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Gymnema inodorum (GI), a vegetable widely used in a Northern Thai food, is known for not only its 
health nourishing effect, but also its hypoglycemic effect. But no scientific evidence on the 
hypoglycemic effect of GI has ever been reported in human. In this study, the effect of GI consumption 
on peak plasma glucose concentrations in healthy subjects was investigated. Either oral glucose load 
(75 g) or standard meal was given to the subjects with respect to the presence or absence of GI 
consumption and postprandial peak glucose levels were compared. When GI was consumed, 15 min 
after oral glucose load, the glucose concentration with GI was significantly lower (130 ± 32 vs. 145 ± 27 
mg/dl, p < 0.05; N = 73). Doubling dose of GI showed much greater decrease in peak blood glucose 
concentration than that of the single dose (108 ± 15 vs. 130 ± 32 mg/dl, p < 0.05). When standard meal 
was used instead of oral glucose load, similar hypoglycemic effect was observed in GI group; 16 out of 
20 subjects had a lowered peak glucose concentration (129 ± 27 vs. 147 ± 39 mg/dl, p < 0.05). In order to 
evaluate the impact of long term GI consumption on plasma glucose concentration and liver function, 
fasting plasma glucose and liver function test (AST, ALT, GGT and ALP) were monitored at days 0, 2, 4, 
7, 14, 21 and 28. The results showed no change in both fasting plasma glucose and liver enzymes. To 
envisage the mechanism of this hypoglycemic effect, GI leaves were extracted with various solvents 
and tested for insulinotropic property in INS-1 cells as well as the determination of its inhibition on α-
glucosidase activity. Neither increase in insulin level nor inhibition of α-glucosidase enzyme was 
observed, suggesting that the hypoglycemic effect of GI is involved with other mechanisms than the 
activation of beta cell or enzymatic inhibition of carbohydrate absorption. 
 





The projection of diabetes mellitus worldwide is increasing 
in an alarming trend. Diabetes itself along with its com-
plications causes psychosocial implications, as well as 
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the disease. Existing treatment options are costly and 
have limited palliative effects. In addition, many current 
therapies to control glycemia have harmful side effects, 
such as hypoglycemia, liver and kidney damage. One 
treatment that is emerging as a potential strategy for the 
management of diabetes is herbal medicine (Yeh et al., 
2003).  
Gymnema sylvestre (GS), the Asclepiad plant which 
grows in tropical forests of South and South-eastern Asia, 
is the well-known herb that has been used for diabetic 
treatment for more than 2,000 years in Ayuravedic medi- 
cine. The medicinally active parts of the plant are the 
leaves and the roots. Recent  clinical  trials  conducted  in 
 




India have shown that an extract of G. sylvestre is useful 
for controlling blood sugar (Shanmugasundaram and 
Panneerselvam, 1981). 
The hypoglycemic action of GS leaves was first docu-
mented in the late 1920s. This action is attributed to 
members of a family of substances called gymnemic 
acids. GS leaves raise insulin levels, according to resear-
ch in healthy volunteers. Based on animal studies, this 
may be due to regeneration of the cells in the pancreas 
that secrete insulin, or by increasing the flow of insulin 
from these cells. Other study using animal models show 
that GS can also reduce glucose absorption from the 
intestine, improve uptake of glucose into cells and prevent 
adrenal hormones from stimulating the liver to produce 
glucose, thereby reducing blood sugar levels 
(Shanmugasundaram et al., 1983, 1990; Baskaran et al., 
1990). 
A number of studies showed that GS extract can inhibit 
glucose absorption in both animal and human intestines 
by suppressing potassium-induced contraction of ileal 
longitudinal muscle. Oral administration of GS extract 
reduced postprandial serum glucose and improved 
glucose tolerance in mildly diabetic rats. The water-
extracted fraction of GS leaves can return fasting blood 
glucose levels to normal after a long period of oral 
administration by revitalization of pancreatic beta cells 
(Murakami et al., 1996; Yoshikawa et al., 1997; Persaud 
et al., 1999; Sugihara et al., 2000). However, GS 
suppresses sweet taste on taste buds and has bitterness, 
therefore it may irritate the flavor of food or drink (Gent et 
al., 1999). 
Gymnema inodorum (GI), also a member of Asclepiad 
strain, is found ubiquitously in South-eastern Asia 
including Thailand. Since GI does not have gustatory 
modifying action, its leaves and stems have been used 
as vegetables for Thai cuisine, especially in the Northern 
and Eastern parts of the country. GI has been shown to 
have an ability to inhibit glucose absorption in guinea pig 
intestines (Shimizu et al., 1997, 2001). Klungsupya et al. 
(2008) found that GI leaves, extracted with both water 
and ethanol, showed high antioxidant activity with 
polyphenols as the major antioxidant. They also found 
that water extraction of young GI leaves can decrease 
blood glucose in alloxan-induced diabetic rats. However, 
the study with regard to hypoglycemic effect of GI has 
never been done in human. For this reason, we studied 
the hypoglycemic effect of GI in healthy human. In 
addition, such possible underlying mechanisms of hypo-
glycemic effect of G. inodorum as the insulinotropic effect 
and the inhibition of the carbohydrate digestive enzyme 
of the intestine (α-glucosidase) were investigated 
 
 




Healthy subjects of both sexes aged 18-25 years old without history 





study. Absence of diabetes was confirmed by evaluating normal 
fasting plasma glucose concentration (70 - 100 mg/dl) and seventy-
three subjects were included. This study was approved by the Ethic 
Committee on Human Studies, Faculty of Medicine, Chulalongkorn 






Fresh G. inodorum (Lour.) Decne was obtained from Chiangmai, 
the Northern Province of Thailand. The sample of GI was sent to 
Forest Herbarium for identification and the voucher specimen is 
BKF 154237. The fresh leaves were used for further extraction. 
GI tea bag was prepared according to the method of Jinda 
Rungruang manufacturer. Briefly, GI leaves collected from a single 
garden were oven-dried and crushed in powder and 1.5 g was 
packed in one tea bag. This tea prepared was subsequently utilized 
for oral glucose load or standard meal study. Before use, one or 
two bags of GI tea was immersed in 150 ml of boiling water and left 
for 5 min. 
 
 
Study of hypoglycemic effect of GI tea in human 
 
The study was designed as a before/after experiment and oral 
glucose tolerance test (OGTT) was used as a tool. The “before” or 
control group was the group of subjects performed OGTT without 
GI tea consumption (n = 73) and the “after” or treatment group was 
the same group of subjects that was studied for OGTT with the 
addition of GI tea consumption. Plasma glucose level was mea-
sured at 0, 15 and 30 min after the oral glucose load (75 g) to 
determine the appropriate time for GI tea consumption. Usually, GI 
tea prepared from one bag was used. The subjects were divided 
into 4 groups. Groups I, II and III subjects drank one bag of GI tea 
immediately, at 15 and 30 min after oral glucose load, respectively, 
while group IV, subjects drank two bags of GI tea at 15 min after 
the oral glucose load. The patterns of OGTT curves were analyzed 
and the peaks of glucose concentration were compared and 
statistically analyzed using Student’s t-test. 
To investigate whether the GI tea has hypoglycemic effect when 
consumed with meal, standard meal prepared from 66 g of 
baguette French bread (glycemic index = 95) and 15 g of 
strawberry jam (1 pack of Smuckers’ strawberry jam, glycemic 
index = 49), total glycemic index of 88 (glycemic load = 72) and 
total calories of 225 kcal was used instead of glucose load. Twenty 
subjects were assigned to eat standard meal and drink one cup of 
GI tea (one bag) at 15 min after the first bite of the meal. Blood 
sample was drawn before taking the meal (0 min) and at 30, 60 and 
120 min after the first bite of the meal. Baseline or control group 
was the same group of subjects that ate standard meal without GI 
tea. The time interval between baseline and treatment condition 
(wash out period) was 7 days. 
To determine the peak plasma glucose concentration, plasma 
glucose was measured using glucose oxidase method (Human 




The effect of long term consumption of GI tea on fasting 
plasma glucose and liver function 
 
Twenty healthy subjects with normal plasma glucose and liver 
function enzymes (aspartate transaminase (AST), alanine transa-
minase (ALT), alkaline phosphatase (ALP) and gamma 
glutamyltransferase (GGT)) were included in this study. During the 
period of 28 days, the subjects were assigned to have daily 






min after their regular lunch, then liver enzymes and fasting plasma 
glucose levels were monitored from blood obtained at days 0, 2, 4, 
7, 14, 21 and 28.  
 
 
Preparation of GI extract 
 
GI leaves were extracted into four fractions according to the method 
of Shimizu et al. (2001). Briefly, the fresh GI leaves were dried at 
60°C and crushed into 0.5 - 2 mm pieces; the dried GI powder was 
pretreated/ decolored with citric acid solution, pH 2.5. The acid-
treated leaves were extracted with an aqueous 50% ethanol 
solution to obtain GI-I and concentrated in a rotary evaporator at 
80°C. After evaporation, partition extractions were performed using 
n-butanol and water in a ratio of 1:1 to obtain n-butanol fraction (GI-
II) and residue fraction was concentrated from aqueous phase. The 
n-butanol fraction was defatted and decolorized with petroleum 
ether. The defatted mixture was filtered and defatted again with 




Culture of INS-1 cells 
 
The INS-1 rat insulinoma cell line (kindly provided by Dr. S. Adisak-
watana, Faculty of Allied health sciences, Chulalongkorn University, 
Thailand) was cultured under 5% CO2/ 95% air at 37°C in the 
RPMI-1640 medium (Invitrogen, Carlsbad, CA) containing 11.2 mM 
glucose and 2 mmol/l L-glutamine. The medium was supplemented 
with 10% fetal bovine serum (FBS), 1 mmol/l pyruvate, 10 mmol/l 
HEPES buffer, pH 7.4, 50 µmol/l 2-mercaptoethanol, 100 units/ml 
penicillin and 100 µg/ml streptomycin. All experiments were perfor-
med using INS-1 cells between the 20th and 30th passages. The 
cells were passed 2 - 4 days before each experiment and plated in 
24-multiwell plates at a density of 5 x 105 cells per well in the 





INS-1 cells (3 x 105 cells/150 µl/well) were cultured on 96-well 
microplates for 24 h. Cells were incubated with various concen-
tration of GI extract (0, 5,10 and 15 mg in 1 ml of 0.2% DMSO) for 
another 24 h. The cultures were incubated with MTT (C,N-diphenyl-
N’-4,5-dimethyl thiazol 2yl tetrazolium bromide) (Sigma, St Louis, 
MO), dissolved in Krebs-Ringer bicarbonate (KRB) buffer, pH 7.4 
(2.5 mM CaCl2, 15 mM NaHCO3, 10 mM HEPES and 0.1% BSA) 
for 4 h. The assay was performed as described by Mosmann, 1983. 
The concentration of 5 mg/ml of GI extract (Fraction I-IV) gave the 
highest percentage of cell viability (data not shown).  
 
 
Measurement of insulin secretion 
 
One day before an insulin release experiment, the glucose concen-
tration in the medium was reduced to 5 mM. Cultured medium was 
replaced using the medium with KRB buffer, pH 7.4, containing 3 
mM glucose. After washing cells twice with Krebs-Ringer-HEPES-
BSA solution, an insulin secretion assay was performed in 1 ml of 
the same solution with or without GI extract. 5 mg of each GI 
extract; GI I-IV fractions were dissolved with 1 ml of 0.2% DMSO 
prior to incubation with INS-1 cells for 1 h at 37°C, then insulin 
secretion was measured. Plates with DMSO were used as negative 
controls. After 1 h at 37°C, the solution was collected and 
centrifuged at 25°C, 2,000 rpm for 10 min. The supernatant fraction 
was removed and saved for insulin measurement. Insulin level in 
culture medium was measured using an immunoradiometric  assay.  




The insulina IRMA kit was purchased from RADIM S.p.A., Italy. The 
experiment was done in duplicate and the results were calculated 
for mean and standard deviation. 
 
 
Measurement of alpha-glucosidase inhibitory activity  
 
Dried GI leaves were extracted with boiling deionized water and 
70% methanol and the extracts were lyophilized before use for the 
determination of inhibitory effect on digestive enzyme, α-glucosidase. 
Acarbose was used as a positive control. The -glucosidase 
inhibitory assay was done by the chromogenic method (Sigma, St 
Louis, MO). In brief, GI extract powders were dissolved in 1 M PBS 
and incubated for 5 min with yeast -glucosidase enzyme, then 
substrate (p-nitrophenyl--D-glucopyranoside) was added and after 
20 min of incubation at 37°C, sodium carbonate was added. The 
reaction tubes were recorded at 405 nm spectrophotometrically. 
The increase in absorbance from pre-substrate addition to post 
substrate reaction was obtained. Percent inhibition was calculated 
by (1-Absorbance test/Absorbance control) × 100 and inhibitory 






Results were expressed as mean ± SD throughout the study. The 
effects of GI extract on peak glucose concentration and insulin level 
were analyzed by one-way and two-way analyses of variance 
(ANOVA) and paired Student’s t-test. All other clinical and para-
meters were analyzed by one-way ANOVA, followed by paired 






Hypoglycemic effect of G. inodorum tea in human 
(OGTT study) 
 
Data in Table 1 showed that drinking GI tea immediately 
and at 15 min after oral glucose load (group I and II) 
could significantly reduce plasma glucose ( p = 0.035 and 
0.004 respectively). Double concentration of GI tea 
(group IV) could reduce plasma glucose better than one 
pack of GI tea drinking (p < 0.001). Drinking GI tea at 30 
min after glucose load (group III) did not reduce plasma 
glucose significantly (p = 0.662). The average values of 
OGTT for all groups were shown in Figure 1. 
 
 
Hypoglycemic effect of GI tea on standard meal 
 
The result showed that 16 out of 20 of the subjects (80%) 
had decreased peak plasma glucose concentration. The 
mean peak glucose concentration in the GI group (treat-
ment group) was significantly lower than that of the 
control group (147 ± 39 vs. 129 ± 27 mg/dl, p = 0.016) as 
shown in Table 2. Thus, G. inodorum tea has hypogly-
cemic effect regardless of glucose source consumed. 
 
 
Effect of GI tea consumption on liver function test 
 
Liver enzymes and fasting glucose  in  blood  of  subjects  
 




Table 1. Hypoglycemic effect of GI tea on peak plasma glucose concentration in 
healthy human.  
 
Group n Average glucose peak (mg/dl) 
Control a 73 145 ± 27.17 
Group I b 40 130 ± 31.50 * 
Group II c 73 131 ± 27.25 ** 
Group III d 20 143 ± 41.18 
Group IV e 19 108 ± 14.49 ** 
 
Data were expressed as mean ± SD.  
aThe subjects performed standard OGTT without GI tea consumption; b the subjects 
drank 1.5 g of GI tea immediately after oral glucose load; c the subjects drank 1.5 g of 
GI tea at 15 min after oral glucose load; d the subjects drank 1.5 g of GI tea at 30 min 
after oral glucose load; e the subjects drank 3.0 g of GI tea at 15 min after oral glucose 
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Figure 1. Effect of oral administration of GI tea (1.5 g) on plasma glucose levels. 




Table 2. Hypoglycemic effect of GI tea on standard meal (n=20). 
 
Group Peak glucose concentration (mg/dl) 
Control 147 ± 39 
Treatment 129 ± 27* 
 




who consumed one pack of GI tea daily for 28 days were 
monitored at days 0, 2, 4, 7, 14, 21 and 28. As shown in 
Table 3 and Figure 2, it was found that there was no 
significant difference with regards to the liver enzymes of 
the control group (no GI tea consumption) and the 
treatment group (with GI tea consumption). The fasting 
plasma glucose of all subjects remained within normal 
limit throughout the period of the study (Figure 3). 
 
 
Effect of GI extract on insulin secretion of INS-1 cells 
 
The result showed that none of GI fractions could stimu-
late insulin secretion from INS-1 cells (Figure 4).  
Study on alpha-glucosidase inhibitory activity of GI 
extract 
 
GI extract with both boiling water and 70% methanol did  





The present study suggested that suitable time for GI tea 
to exert its hypoglycemic effect is to drink the tea 
immediately or at 15 min after oral glucose load or meal 
(groups I and II), but not at 30 min (group III). One pack 
of GI tea can significantly  reduce  peak  plasma  glucose  
 




Table 3. Liver function test (AST, ALT, ALP, GGT) in healthy 
subjects (n = 20) after 28 days of GI tea consumption. 
 
Liver enzyme Baselinea Treatmentb P-value 
AST 17.2 ± 6.4 18.3 ± 3.3 0.872 
ALT 12.3 ± 4.5 13.1 ± 3.3 0.475 
ALP 72.4 ± 7.4 73.8 ± 8.0 0.100 
GGT 17.8 ± 4.5 18.4 ± 5.0 0.759 
 
Each value is mean ± SD.  
a ‘Baseline’ is the liver enzyme level measured at day 0 before the 
treatment; b ‘treatment’ is the liver enzyme level measured after GI tea 
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Figure 2. Average liver function profile (AST, ALT, ALP, GGT) in healthy 















Fasting plasma glucose monitoring 
 
 
Figure 3. Fasting plasma glucose in healthy subjects within 28 




10 and 11%, respectively, and more reduction (25%) was 
obtained with double dosage of GI (group IV). This dose-
responsive finding confirms the hypoglycemic activity of 
GI. Natalucci et al. (2003) studied a pattern of glucose 
absorption from OGTT and found that the average rate of 
glucose appearance into plasma was highest at time 30 - 
45 min after glucose load. This may explain why drinking 
GI tea at 30 min after glucose load cannot reduce peak 
plasma glucose. At 30 min, glucose was readily absorbed 
and transported to blood circulation thus GI cannot 
display its effect. 
-Glucosidase (EC 3.2.1.20) is an enzyme that hydro-
lyzes -glucosides to glucose. It is usually found at the 
brush border of the small intestinal epithelium, where it 
can hydrolyze oligosaccharides, trisaccharides and 
disaccharides such as maltose to glucose and other 
saccharides for absorption. -Glucosidase inhibitor can 
act as a competitive inhibitor of  -glucosidase;  hence,  it  
 















































Figure 4. Effects of GI extract on insulin secretion in INS-1 cells. The insulin in each well was 
measured by Insulina IRMA kit (125I) as before and after glucose addition. The figures are the 
average of the duplicate study. C = control group; measure insulin release from INS-1 cell; 
Group 1= INS-1 cell treated with GI extract from boiling water; Group 2 = INS-1 cell treated 
with GI I fraction (ethanol extract); Group 3 = INS-1 cell treated with GI II fraction (n-butanol 
extract); Group 4 = INS-1 cell treated with GI III fraction (ethyl acetate extract); Group 5 = 
INS-1 cell treated with GI IV fraction (methanol extract). 
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Figure 5. Effect of GI extracted with water and 70% methanol on inhibition of 




reduces the impact of carbohydrates on blood sugar 
(Kakavanos et al., 2006).  
Inhibition of -glucosidase activity is one possible 
mechanism for the hypoglycemic effect of certain medi-
cinal herbs used for diabetes therapy such as Rosa 
damascene (rose), Rosmarinus offinalis (rosemary), 
Pistacia vera (pistachio), Entada rheedii (African dream 
herb) and Albizia lebbeck (lebbeck-tree) (Gholamhoseinian 
et al., 2008; Tunsaringkarn et al., 2008). In this study, the 
-glucosidase inhibitory property of GI leave extracts was 
tested both with water and methanol, but no inhibitory 
effect on -glucosidase enzyme was found. The present 
finding is in accordance with the study of Sugihara et al. 
(2000) who also found that gymnemic acid IV, a com-
pound derived from G. sylvestre leaves (1 mg/ml) did not 
inhibit -glucosidase activity in the brush border mem-
brane vesicles of normal rat small intestines.  
Shimizu et al. (1997, 2001) showed that the crude 
saponin mixtures extracted from GI leaves can inhibit 
glucose absorption in the isolated intestinal tract and 
suppressed the increased blood glucose in rats. They 
found that triterpenoid saponin in GI extracts can sup-
press the high K+-induced contraction of intestinal smooth 
muscle which affected Na+/K+ pump. When the pump was 
suppressed, the electrochemical potential of Na+ inside 






transport system. Thus, this experimental evidence is 
suggested to be the possible mechanism of the inhibitory 
effect of GI on glucose absorption from the intestinal 
tract.  
The insulinotropic action of the extract of GI was further 
investigated using INS-1 rat insulinoma cell line and 
immunoradioassay. It was found that GI extracts failed to 
increase insulin secretion from the INS-1 cells after 
incubating with GI extract for 1 h. The finding that GI 
extract could not stimulate insulin secretion in INS-1 cells 
despite its hypoglycemic effect in the oral glucose tole-
rance test may explain that GI lowers blood glucose 
concentration via incretins-insulin stimulation which can 
occur only in vivo. Consumption of GI after meal may 
stimulate more incretins secretion from small intestine 
and the incretins further stimulate pancreatic β-cells to 
secrete insulin resulting in the decrease of blood glucose 
concentration (Baggio and Drucker, 2007). Since 
incretins have very short half-life in blood and is not 
possible to measure, the measurement of plasma insulin 
after GI consumption with meal will elucidate this 
hypothesis. As well, further study is needed to explore 
this activity on long-term use in human. 
In this study, commercial GI was used and the product 
has been approved by Thai Food and Drug Admini-
stration (FDA) for consumption as a regular beverage. To 
confirm the safety of GI tea, a group of 20 healthy 
subjects was studied and it was found that GI tea has no 
toxicity to liver upon a once daily consumption for 28 
days. Furthermore, GI tea did not reduce normal fasting 
plasma glucose level in healthy human after this period. 
This may implied that daily consumption of one pack of 





G. inodorum has hypoglycemic effect in healthy human. 
Consumption of GI tea with meal or 15 min after meal 
can significantly decrease peak plasma glucose. Double 
dose of GI reduce peak plasma glucose in a dose-
responsive manner. Long term consumption of GI for 28 
days does not cause fasting hypoglycemia or hepatoto-
xicity. The mechanism of this hypoglycemic effect does 
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